Stephen Chambers
InvestorGeneral Partner at SOSV
New York, New York
Writes $100K – $2M checks · typically $1M
Find your path to Stephen
436 people in our graph share verified history with Stephen — schools, employers, funds. One of them is your warm intro.
About
Stephen Chambers is a General Partner at SOSV and Managing Director of SOSV NY, which he co-founded in 2020 after mentoring the program's life science startups since 2018. He holds a PhD in Molecular Biology and has extensive pharma entrepreneurship experience, having been a founding scientist at Vertex Pharmaceuticals, co-founded Abpro Therapeutics, and served as CEO of SynbiCITE and co-founder of the UK accelerator Bio-start.
Experience
- SOSVManaging Director & General Partner at SOSV NYcurrent2020 — presentNew York, United States
- Imperial College LondonRoyal Society Entrepreneur in Residence2019 — 2021Greater London, England, United Kingdom
- Bio-startCo Founder2016 — 2018Greater London, England, United Kingdom
- SynbiCITECEO2014 — 2018Greater London, England, United Kingdom
- London DNA FoundryAdvisory Board Member2014 — 2018Greater London, England, United Kingdom
- AbproCo Founder2008 — 2013Lexington, MA, USA
- Vertex PharmaceuticalsDirector of Gene Expression1990 — 2007Cambridge, MA, USA
Skills & more
+12 more
InvestmentFundraisingInvestmentsBiochemistryBiotechnologyProtein ChemistryMolecular BiologyDrug DiscoveryStart-upsCell CultureLifesciencesCell BiologyFrom Stephen's professional profile.
Investments
Investor
5h45AIMAAnomer BioArgentagAromatEcoAsta BioAthos BioindustriesAvantGuardBacteryBasin GenomicsBeemmunityBioeutecticsBioFluffBioLatticeBiomageBosque FoodsBrickBuilt TherapeuticsBrightCureBucha BioBugBiomeCalder BiosciencesCapro-XCare ConstitutionCayuga BiotechCell BioEnginesCellCodexCeragenCircadianConan MedTechCroBioDeep Root BiolabsDipteraEachdayEarnest AgricultureEdge FoodsFluoSpheraForage EvolutionForte ProteinFoundational BioFree to FeedFREZENTGiraffe Bioharmony baby nutritionHelexHexem BioInnatrixInso BiosciencesiOrganBioJanusKalia HealthKlona BiotechKolibriKutaniosKyomeiLizarBio TherapeuticsLux BioMateria BioworksmicroTERRAMoonlight TherapeuticsMothership MaterialsMultusNanoPlumeNat4BioNukokoPalate TherapeuticsPannex Therapeutics Inc.PneumaPrimary BioscienceQuorum EarthRizlab HealthSable TherapeuticsSci-Lume LabsSemionSEQUENTIALStarstone BiomaterialsStembionixTastee TapeTerra Bioindustries Inc.TesaraktTinkeso TherapeuticsTômtexUprightVader NanotechnologiesVine MedicalVitarka TherapeuticsXias Bio
Per curated public sources.
Colleagues at SOSV
Network2
Investors connected to Stephen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Stephen Chambers?
- Stephen Chambers is a General Partner at SOSV and Managing Director of SOSV NY, which he co-founded in 2020 after mentoring the program's life science startups since 2018. He holds a PhD in Molecular Biology and has extensive pharma entrepreneurship experience, having been a founding scientist at Vertex Pharmaceuticals, co-founded Abpro Therapeutics, and served as CEO of SynbiCITE and co-founder of the UK accelerator Bio-start.
- Where does Stephen Chambers work?
- Stephen Chambers is General Partner at SOSV.
- What check size does Stephen Chambers write?
- Stephen Chambers typically writes checks of $100K – $2M.
- What companies has Stephen Chambers invested in?
- Investments tracked here include 5h45, AIMA, Anomer Bio, Argentag, AromatEco, Asta Bio, Athos Bioindustries, AvantGuard, Bactery, Basin Genomics, Beemmunity, Bioeutectics, and 74 more.
- Where did Stephen Chambers go to school?
- Stephen Chambers studied at University of Warwick (PhD, Molecular Biology); University of Birmingham (MS, Biotechnology); Bangor University (BS, Biochemistry).
Same school
Also attended University of Warwick254
+ 248 more
Also attended University of Birmingham177
+ 171 more
Also attended Bangor University17
+ 11 more
Shared employers
Also worked at Imperial College London234
+ 228 more
Also worked at Abpro1
Also worked at Vertex Pharmaceuticals60
+ 54 more













































